Diabetes Care Devices Market Revenue to Attain USD 111.38 Bn by 2033

07 Aug 2025

Share :

Table of Content

1. Diabetes Care Devices Market Revenue and Trends 2025 to 2033 2. What are the Major Factors Driving the Growth of the Diabetes Care Devices Market? 3. Segment Insights 4. Regional Insights 5. Diabetes Care Devices Market Coverage 6. Diabetes Care Devices Market Key Players

Diabetes Care Devices Market Revenue and Trends 2025 to 2033

The global diabetes care devices market revenue surpass USD 68.57 billion in 2025 and is predicted to attain around USD 111.38 billion by 2033, growing at a CAGR of 6.25%. The market growth is attributed to the growing global prevalence of diabetes, increasing demand for advanced monitoring solutions, and greater emphasis on personalized, home-based disease management.

What are the Major Factors Driving the Growth of the Diabetes Care Devices Market?

Several key factors drive the growth of the market for diabetes care devices. Firstly, the increasing prevalence of diabetes, especially type 2, is due to sedentary lifestyles, an aging population, and dietary habits. Diabetes often requires regular monitoring of glucose levels to manage symptoms and reduce the risks of complications, which is expanding the consumer base of diabetes care devices. Secondly, advancements in glucose monitoring devices, which improve disease management and outcomes, are likely to boost the consumer adoption rate. Furthermore, rising consumer awareness, more frequent discussions with doctors about early diagnosis, supportive government initiatives, including reimbursement programs, and the integration of digital health and remote monitoring platforms are all contributing to market growth.

Segment Insights

• By product type, the blood glucose monitoring devices segment sustained dominance in the market while holding the largest share in 2024, driven by the increased need for accurate and real-time glucose tracking. 
• By end-user, the homecare settings segment held the largest share of the market in 2024, fueled by the growing number of patients seeking accessible, cost-effective, and self-managed diabetes care monitoring. The growing trend of self-care further boosts the demand for user-friendly devices for home use.
• By distribution channel, the institutional sales segment dominated the diabetes care devices market with a major share in 2024 due to its crucial role in ensuring timely delivery to end-users. Hospitals and clinics can purchase devices and supplies in bulk through this channel, ensuring supply reliability and affordability.
• By patient type, the type 2 diabetes segment led the market for diabetes care devices in 2024 due to its high prevalence worldwide. Type 2 diabetes often requires long-term diabetes management, boosting the demand for diabetes care devices.
• By usage type, the therapeutic use segment dominated the market in 2024, driven by the increased need for effective and efficient insulin delivery and monitoring devices to manage condition.

Regional Insights

North America registered dominance in the diabetes care devices market in 2024. The region’s dominance stems from its advanced healthcare systems, high prevalence of diabetes, and widespread use of innovative technologies such as CGMs and insulin pumps. The presence of leading medical device manufacturers and the rising demand for personalized medicine further support market growth.

Meanwhile, Asia-Pacific is considered to be the fastest-growing area due to an increasing diabetic population, advancing healthcare systems, and growing awareness about the ongoing management of diabetes. Government initiatives and growing investments in digital health are further accelerating market expansion.

Diabetes Care Devices Market Coverage

Recent Development

• On April 10, 2025, the FDA cleared the Dexcom G7 15 Day CGM system for individuals age 18 years and older with diabetes. This system is a wearable sensor that continuously measures glucose levels and transmits readings every 5 minutes with no fingersticks or scanning required. 
  (Source: https://www.empr.com)

Diabetes Care Devices Market Key Players

• Abbott Laboratories
• Medtronic plc
• F. Hoffmann-La Roche Ltd
• Dexcom, Inc.
• Ascensia Diabetes Care (PHC Holdings)
• LifeScan, Inc.
• Insulet Corporation
• Tandem Diabetes Care, Inc.
• B. Braun Melsungen AG
• Ypsomed AG
• Terumo Corporation
• Novo Nordisk A/S
• Eli Lilly and Company
• Sanofi S.A.
• Glooko, Inc.
• Senseonics Holdings, Inc.
• ARKRAY, Inc.
• Nipro Corporation
• Embecta Corp
• AgaMatrix, Inc

Get this report to explore global market size, share, CAGR, and trends, featuring detailed segmental analysis and an insightful competitive landscape overview @ https://www.precedenceresearch.com/sample/6536

You can place an order or ask any questions, please feel free to contact at sales@precedenceresearch.com |+1 804 441 9344